Search Results

Active, currently enrolling    Who can join   

A Phase II, multi-site, randomized, open-label clinical trial to evaluate the safety, efficacy, and pharmacokinetics of BNT327 at two dose levels in combination with chemotherapeutic agents as first- and second-line treatment in triple-negative breast cancer

Keywords: Oncology (Adult);
Study Type: Clinical Trial   |  Region: Hawaii

---

Enrollment complete    Who can join   

Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer

Keywords: Oncology (Adult); RTOG-1016; stage III squamous cell carcinoma of the…
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment complete    Who can join   

A Prospective Observational Cohort Study to Assess miRNA 371 for Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors

Keywords: Oncology (Adult);Other;
Study Type: Clinical Trial   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

A Phase 2, Randomized, Open-label Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Patients With a KRAS or NRAS Mutation

Keywords: Oncology (Adult);
Study Type: Clinical Trial   |  Region: Hawaii

---

Active, currently enrolling    Who can join   

A Phase 1b/2, Randomized, Open-Label Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy in Patients With Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer

Keywords: Oncology (Adult);Gastroenterology;
Study Type: Clinical Trial   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

OptimICE-pCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy

Keywords: Obstetrics and Gynecology;Oncology (Adult);
Study Type: Clinical Trial   |  Region: Colorado

---

Enrollment complete    Who can join   

Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment complete    Who can join   

Intergroup Randomized Phase 2 Four Arm Study In Patients = 60 With Previously Untreated Mantle Cell Lymphoma Of Therapy With: Arm A = Rituximab+ Bendamustine Followed By Rituximab Consolidation (RB ? R); Arm B = Rituximab + Bendamustine + Bortezomib Followed By Rituximab Consolidation (RBV? R), Arm C = Rituximab + Bendamustine Followed By Lenalidomide + Rituximab Consolidation (RB ? LR) or Arm D

Keywords: Oncology (Adult); E1411; neurotoxicity; therapy-related toxicity; contiguous…
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment complete    Who can join   

A Phase 1b Study to Evaluate the Safety and Clinical Activity of AB122 in Biomarker-Selected Participants With Advanced Solid Tumors

Keywords: Oncology (Adult); AB122CSP0002; Neoplasms;
Study Type: Clinical Trial   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

Multiple Patient Program for Lamprene (clofazimine) for Treatment of Non-Tuberculosis Mycobacterial (NTM) Infections

Keywords: Oncology (Adult);Infectious Diseases;
Study Type: Prospective Cohort Study with Direct Patient Contact   |  Region: Colorado

---